Abstract
Chronic inflammation in adipose tissue is the hallmark of obesity and a major risk factor for the development of obesity-induced insulin resistance. NLRP3 inflammasome regulates the maturation and secretion of pro-inflammatory cytokines, such as IL-1β and IL-18, and was recently discovered to be involved in obesity-related metabolic diseases. Fibroblast growth factors (FGFs) such as FGF1, FGF10, and FGF21 are adipokines that regulate adipocyte development and metabolism, but reports on the effect of other FGFs on adipocytes are lacking. In the present study, the novel role of FGF2 in NLRP3 inflammasome activation was elucidated. Our results showed that FGF2 levels were increased during adipocyte differentiation and in the adipose tissue of high-fat diet (HFD)-induced obese mice. Recombinant FGF2 treatment upregulated inflammasome markers such as NLRP3, which was further exaggerated by TNF-ɑ treatment. Interestingly, β-Klotho, a co-receptor of FGF21, was significantly decreased by FGF2 treatment. Results from mice confirmed the positive correlation between FGF2 and NLRP3 expression in epididymal and subcutaneous adipose tissue, while exercise training effectively reversed HFD-induced NLRP3 expression as well as FGF2 levels in both adipose depots. Our results suggest that FGF2 is an adipokine that may exacerbate the inflammatory response in adipocytes through NLRP3 inflammasome activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benham V, Chakraborty D, Bullard B, Bernard JJ (2018) A role for FGF2 in visceral adiposity-associated mammary epithelial transformation. Adipocyte 7:113–120. https://doi.org/10.1080/21623945.2018.1445889
Bluher M (2019) Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 15:288–298. https://doi.org/10.1038/s41574-019-0176-8
Camell CD, Gunther P, Lee A, Goldberg EL, Spadaro O, Youm YH, Bartke A, Hubbard GB, Ikeno Y, Ruddle NH, Schultze J, Dixit VD (2019) Aging induces an Nlrp3 inflammasome-dependent expansion of adipose B cells that impairs metabolic homeostasis. Cell Metab 30:1024–1039 e1026. https://doi.org/10.1016/j.cmet.2019.10.006
Chakraborty D, Benham V, Bullard B, Kearney T, Hsia HC, Gibbon D, Demireva EY, Lunt SY, Bernard JJ (2017) Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer. Oncogene 36:6668–6679. https://doi.org/10.1038/onc.2017.278
Chien SY, Huang CY, Tsai CH, Wang SW, Lin YM, Tang CH (2016) Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes. Clin Sci (Lond) 130:667–681. https://doi.org/10.1042/cs20150622
Chihara Y, Rakugi H, Ishikawa K, Ikushima M, Maekawa Y, Ohta J, Kida I, Ogihara T (2006) Klotho protein promotes adipocyte differentiation. Endocrinology 147:3835–3842. https://doi.org/10.1210/en.2005-1529
Choi Y, Jang S, Choi MS, Ryoo ZY, Park T (2016) Increased expression of FGF1-mediated signaling molecules in adipose tissue of obese mice. J Physiol Biochem 72:157–167. https://doi.org/10.1007/s13105-016-0468-6
Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349–356. https://doi.org/10.1079/pns2001110
Diaz-Delfin J, Hondares E, Iglesias R, Giralt M, Caelles C, Villarroya F (2012) TNF-alpha represses beta-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology 153:4238–4245. https://doi.org/10.1210/en.2012-1193
Dong Z, Santeford A, Ban N, Lee TJ, Smith C, Ornitz DM, Apte RS (2019) FGF2-induced STAT3 activation regulates pathologic neovascularization. Exp Eye Res 187:107775. https://doi.org/10.1016/j.exer.2019.107775
Fujii T, Yonemitsu Y, Onimaru M, Tanii M, Nakano T, Egashira K, Takehara T, Inoue M, Hasegawa M, Kuwano H, Sueishi K (2006) Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol 26:2483–2489. https://doi.org/10.1161/01.ATV.0000244684.23499.bf
Gabrielsson BG, Johansson JM, Jennische E, Jernås M, Itoh Y, Peltonen M, Olbers T, Lönn L, Lönroth H, Sjöström L, Carlsson B, Carlsson LM, Lönn M (2002) Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes Res 10:608–616. https://doi.org/10.1038/oby.2002.83
Geng L, Liao B, Jin L, Huang Z, Triggle CR, Ding H, Zhang J, Huang Y, Lin Z, Xu A (2019) Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues. Cell Rep 26:2738–2752 e2734. https://doi.org/10.1016/j.celrep.2019.02.014
Giordano A, Murano I, Mondini E, Perugini J, Smorlesi A, Severi I, Barazzoni R, Scherer PE, Cinti S (2013) Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res 54:2423–2436. https://doi.org/10.1194/jlr.M038638
Guan X, Nie L, He T, Yang K, Xiao T, Wang S, Huang Y, Zhang J, Wang J, Sharma K, Liu Y, Zhao J (2014) Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling. J Pathol 234:560–572. https://doi.org/10.1002/path.4420
Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U (2015) Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab 26:193–200. https://doi.org/10.1016/j.tem.2015.01.006
Hao RH, Guo Y, Dong SS, Weng GZ, Yan H, Zhu DL, Chen XF, Chen JB, Yang TL (2016) Associations of plasma FGF2 levels and polymorphisms in the FGF2 gene with obesity phenotypes in Han Chinese population. Sci Rep 6:19868. https://doi.org/10.1038/srep19868
Huh JY (2018) The role of exercise-induced myokines in regulating metabolism. Arch Pharm Res 41:14–29. https://doi.org/10.1007/s12272-017-0994-y
Huh JY, Mougios V, Kabasakalis A, Fatouros I, Siopi A, Douroudos II, Filippaios A, Panagiotou G, Park KH, Mantzoros CS (2014) Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab 99:E2154–E2161. https://doi.org/10.1210/jc.2014-1437
Incio J, Ligibel JA, Mcmanus DT, Suboj P, Jung K (2018) Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. Sci Transl Med 10:eaag0945. https://doi.org/10.1126/scitranslmed.aag0945
Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846. https://doi.org/10.1038/nature05482
Kakudo N, Shimotsuma A, Kusumoto K (2007) Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun 359:239–244. https://doi.org/10.1016/j.bbrc.2007.05.070
Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Investig 116:1494–1505. https://doi.org/10.1172/JCI26498
Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y (1998) De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 95:1062–1066. https://doi.org/10.1073/pnas.95.3.1062
Keller M, Rüegg A, Werner S, Beer HD (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831. https://doi.org/10.1016/j.cell.2007.12.040
Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. https://doi.org/10.3390/ijms20133328
Kihira Y, Yamano N, Izawa-Ishizawa Y, Ishizawa K, Ikeda Y, Tsuchiya K, Tamaki T, Tomita S (2011) Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1alpha in adipocytes. Int J Biochem Cell Biol 43:1602–1611. https://doi.org/10.1016/j.biocel.2011.07.009
Klöting N, Blüher M (2014) Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 15:277–287. https://doi.org/10.1007/s11154-014-9301-0
Kühn MC, Willenberg HS, Schott M, Papewalis C, Stumpf U, Flohé S, Scherbaum WA, Schinner S (2012) Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. Mol Cell Endocrinol 349:180–188. https://doi.org/10.1016/j.mce.2011.10.018
Kwon H, Pessin JE (2013) Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) 4:71. https://doi.org/10.3389/fendo.2013.00071
Lee J (2013) Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Arch Pharm Res 36:208–222. https://doi.org/10.1007/s12272-013-0023-8
Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK (2013) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62:194–204. https://doi.org/10.2337/db12-0420
Liu Z, Gan L, Xu Y, Luo D, Ren Q, Wu S, Sun C (2017) Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res 63:e12414. https://doi.org/10.1111/jpi.12414
Moncion A, Lin M, O’neill EG, Franceschi RT, Kripfgans OD, Putnam AJ, Fabiilli ML (2017) Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds. Biomaterials 140:26–36. https://doi.org/10.1016/j.biomaterials.2017.06.012
Mydlo JH, Kral JG, Macchia RJ (1998) Preliminary results comparing the recovery of basic fibroblast growth factor (FGF-2) in adipose tissue and benign and malignant renal tissue. J Urol 159:2159–2163. https://doi.org/10.1016/S0022-5347(01)63298-1
Ncd-Risc (2016) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387:1377–1396. https://doi.org/10.1016/s0140-6736(16)30054-x
Neubauer M, Fischbach C, Bauer-Kreisel P, Lieb E, Hacker M, Tessmar J, Schulz MB, Goepferich A, Blunk T (2004) Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 577:277–283. https://doi.org/10.1016/j.febslet.2004.10.020
Ohta H, Itoh N (2014) Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism. Front Endocrinol (Lausanne) 5:18. https://doi.org/10.3389/fendo.2014.00018
Okla M, Zaher W, Alfayez M, Chung S (2018) Inhibitory effects of toll-like receptor 4, NLRP3 inflammasome, and interleukin-1beta on white adipocyte browning. Inflammation 41:626–642. https://doi.org/10.1007/s10753-017-0718-y
Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2:Reviews3005. https://doi.org/10.1186/gb-2001-2-3-reviews3005
Patel NG, Kumar S, Eggo MC (2005) Essential role of fibroblast growth factor signaling in preadipoctye differentiation. J Clin Endocrinol Metab 90:1226–1232. https://doi.org/10.1210/jc.2004-1309
Pham DV, Park PH (2020) Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. Arch Pharm Res. https://doi.org/10.1007/s12272-020-01274-7
Presta M, Andres G, Leali D, Dell’era P, Ronca R (2009) Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur Cytokine Netw 20:39–50. https://doi.org/10.1684/ecn.2009.0155
Pulgaron ER, Delamater AM (2014) Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diabetes Rep 14:508. https://doi.org/10.1007/s11892-014-0508-y
Razzaque MS (2012) The role of Klotho in energy metabolism. Nat Rev Endocrinol 8:579–587. https://doi.org/10.1038/nrendo.2012.75
Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6:399–409. https://doi.org/10.1038/nrcardio.2009.55
Schäfer T, Zentgraf H, Zehe C, Brügger B, Bernhagen J, Nickel W (2004) Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 279:6244–6251. https://doi.org/10.1074/jbc.M310500200
Sitia R, Rubartelli A (2020) Evolution, role in inflammation, and redox control of leaderless secretory proteins. J Biol Chem 295:7799–7811. https://doi.org/10.1074/jbc.REV119.008907
Stienstra R, Joosten LA, Koenen T, Van Tits B, Van Diepen JA, Van Den Berg SA, Rensen PC, Voshol PJ, Fantuzzi G, Hijmans A, Kersten S, Muller M, Van Den Berg WB, Van Rooijen N, Wabitsch M, Kullberg BJ, Van Der Meer JW, Kanneganti T, Tack CJ, Netea MG (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12:593–605. https://doi.org/10.1016/j.cmet.2010.11.011
Strand ME, Herum KM, Rana ZA, Skrbic B, Askevold ET, Dahl CP, Vistnes M, Hasic A, Kvaløy H, Sjaastad I, Carlson CR, Tønnessen T, Gullestad L, Christensen G, Lunde IG (2013) Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart. FEBS J 280:2228–2247. https://doi.org/10.1111/febs.12161
Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481:278–286. https://doi.org/10.1038/nature10759
Strunz CMC, Roggerio A, Cruz PL, Pacanaro AP, Salemi VMC, Benvenuti LA, Mansur AP, Irigoyen MC (2017) Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes. J Nutr Biochem 40:219–227. https://doi.org/10.1016/j.jnutbio.2016.11.015
Su X, Kong Y, Peng D (2019) Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clin Chim Acta 498:30–37. https://doi.org/10.1016/j.cca.2019.08.005
Teichert-Kuliszewska K, Hamilton BS, Deitel M, Roncari DA (1992) Augmented production of heparin-binding mitogenic proteins by preadipocytes from massively obese persons. J Clin Investig 90:1226–1231. https://doi.org/10.1172/jci115984
Yu JW, Lee MS (2016) Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch Pharm Res 39:1503–1518. https://doi.org/10.1007/s12272-016-0827-4
Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW (2010) Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010:218142. https://doi.org/10.4061/2010/218142
Zhang H, Li Y, Fan Y, Wu J, Zhao B, Guan Y, Chien S, Wang N (2008) Klotho is a target gene of PPAR-gamma. Kidney Int 74:732–739. https://doi.org/10.1038/ki.2008.244
Zhang T, Guan H, Yang K (2010) Keratinocyte growth factor promotes preadipocyte proliferation via an autocrine mechanism. J Cell Biochem 109:737–746. https://doi.org/10.1002/jcb.22452
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140. https://doi.org/10.1038/ni.1831
Zimering MB, Eng J (1996) Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 81:4446–4452. https://doi.org/10.1210/jcem.81.12.8954057
Zimering MB, Anderson RJ, Ge L, Moritz TE (2011) Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus. Metabolism 60:284–291. https://doi.org/10.1016/j.metabol.2010.02.003
Acknowledgements
This study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2018R1C1B6003470).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
ZhuGe, DL., Javaid, H.M.A., Sahar, N.E. et al. Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation. Arch. Pharm. Res. 43, 1311–1324 (2020). https://doi.org/10.1007/s12272-020-01295-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01295-2